Q1 FY27 results: revenue up 22%, PAT up 35%, Cost Auditor re-appointed
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 0.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Agarwal's Eye Hospital posted strong Q1 FY27 results. Revenue from operations rose about 22 percent YoY to INR 142.97 crore versus INR 116.92 crore. Net profit after tax jumped around 35 percent YoY to INR 23.38 crore. EBITDA stood at INR 45.22 crore. EPS rose to INR 48.38. Board also re-appointed M/s. B Y and Associates as Cost Auditors for FY 2026-27. The merger with holding company Dr. Agarwal's Health Care is awaiting NCLT sanction.
Strong quarterly performance signals healthy business growth; pending merger with parent company could simplify group structure.